The UK life science instrumentation market is estimated to grow at a CAGR of around 5.7% significantly during the forecast period owing to the growing advancement in the life science coupled significant R&D and pharmaceutical industry, rising adoption of cell culture technologies and others. Moreover, significant prevalence of infectious and targeted diseases coupled growing research on these diseases further provide significant growth to the market during the forecast period. Furthermore, the UK life science instrumentation market is segmented on the basis of technology and end-user.
Based on the technology, the market is further classified into chromatography, spectroscopy, polymerase chain reaction (PCR), clinical chemistry analyzers, immunoassays, next-generation sequencing (NGS), flow cytometry, microscopy, and others (centrifuges, electrophoresis). The NGS segment is projected to have considerable growth during the forecast period owing to the increasing application in sequencing for cancer-based research. Based on the end-user, the UK life science instrumentation market is further segmented into pharmaceutical & biotechnology companies, research institutes, and hospitals & laboratories. The pharmaceutical & biotechnology companies segment estimated to grow at a considerable CAGR during the forecast.
Furthermore, the UK life science instrumentation market is characterized by the presence of several market players that are catering to a wide range of customers across the globe. Some of the key players in the market include Biomerieux S.A., Carl Zeiss AG, Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific, Inc., Tecan Trading AG and others. These players adopt various strategies to remain competitive in the market and gain a competitive advantage over other players operating in the market. Mergers and acquisitions, product launch, and partnerships and collaborations, and geographical expansion are some of the major activities adopted by the market players.
Research Methodology
The market study of the UK life science instrumentation market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for life science instrumentation market players, the medical device industry, contract manufacturers, research institutes, distributors & traders, industry associates & experts, government organizations, regulatory bodies, and other market participants for the overall market and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the UK Life Science Instrumentation Industry
• Recovery Scenario of UK Life Science Instrumentation Industry
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on key players
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. UK Life Science Instrumentation Market by Technology
5.1.1. Chromatography
5.1.2. Spectroscopy
5.1.3. Polymerase Chain Reaction (PCR)
5.1.4. Clinical Chemistry Analyzers
5.1.5. Immunoassays
5.1.6. Next Generation Sequencing (NGS)
5.1.7. Flow Cytometry
5.1.8. Microscopy
5.1.9. Others (Centrifuges, Electrophoresis)
5.2. UK Life Science Instrumentation Market by End-User
5.2.1. Pharmaceutical & Biotechnology Companies
5.2.2. Research Institutes
5.2.3. Hospitals and Laboratories
6. Company Profiles
6.1. Biomerieux S.A.
6.2. Carl Zeiss AG
6.3. Danaher Corp.
6.4. Eppendorf AG
6.5. General Electric Co.
6.6. Illumina, Inc.
6.7. Merck KGaA
6.8. QIAGEN N.V.
6.9. Thermo Fisher Scientific Inc.
6.10. Tecan Trading AG
1. UK LIFE SCIENCE INSTRUMENTATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
2. UK LIFE SCIENCE INSTRUMENTATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
1. IMPACT OF COVID-19 ON UK LIFE SCIENCE INSTRUMENTATION MARKET, 2020-2027 (% MILLION)
2. IMPACT OF COVID-19 ON UK LIFE SCIENCE INSTRUMENTATION MARKET BY SEGMENT, 2020-2027 (% MILLION)
3. RECOVERY OF UK LIFE SCIENCE INSTRUMENTATION MARKET, 2020-2027 (%)
4. UK LIFE SCIENCE INSTRUMENTATION MARKET SHARE BY TECHNOLOGY, 2020 VS 2027 (%)
5. UK LIFE SCIENCE INSTRUMENTATION MARKET SHARE BY END-USER, 2020 VS 2027 (%)
6. UK LIFE SCIENCE INSTRUMENTATION MARKET SIZE, 2020-2027($ MILLION)